Dunhill Financial’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43 Buy
29
+28
+2,800% +$688 ﹤0.01% 1682
2026
Q2
$32 Hold
1
– – ﹤0.01% 1558
2026
Q1
$20 Sell
1
-1
-50% -$16 ﹤0.01% 1766
2025
Q4
$24 Buy
+2
New +$33 ﹤0.01% 1867

Other funds holding ADPT

Dunhill Financial's ADPT Position: Q3 2026 in Review

Dunhill Financial increased its Adaptive Biotechnologies (ADPT) stake by 2,800% in Q3 2026, buying an estimated $688 and bringing the position to 29 shares worth $43. The position accounts for ﹤0.01% of the portfolio, ranked #1682.

Dunhill Financial first reported a position in ADPT in Q4 2025 and has held it in 4 quarters since. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Dunhill Financial held 29 shares of Adaptive Biotechnologies worth $43 as of Q3 2026.
  • Dunhill Financial bought 28 Adaptive Biotechnologies shares in Q3 2026, an estimated $688.
  • Adaptive Biotechnologies made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #1682 holding.
  • Dunhill Financial first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 4 quarters since.
  • 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.